Target Price | $5.00 |
Price | $1.02 |
Potential |
390.20%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Spero Therapeutics, Inc. 2025 .
The average Spero Therapeutics, Inc. target price is $5.00.
This is
390.20%
register free of charge
$5.00
390.20%
register free of charge
$5.00
390.20%
register free of charge
|
|
A rating was issued by 4 analysts: 2 Analysts recommend Spero Therapeutics, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Spero Therapeutics, Inc. stock has an average upside potential 2025 of
390.20%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 96.74 | 36.94 |
99.14% | 61.81% |
3 Analysts have issued a sales forecast Spero Therapeutics, Inc. 2024 . The average Spero Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
Dec '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | negative |
Based on analysts' sales estimates for 2024, the Spero Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Spero Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.